Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia.

Shuzhen WangXin ZhangTao HanWen XieYonggang LiHong MaRoman LiebeHonglei WengHui-Guo Ding

Published in: BMC gastroenterology (2018)

Clinical trial one: ClinicalTrials.gov ID: NCT00664014 , Registered on April 14, 2008. Clinical trial two: ClinicalTrials.gov ID: NCT01349335 , Registered on March 5, 2010. Clinical trial three: ClinicalTrials.gov ID: NCT01349348 , Registered on May 4, 2011.

Keyphrases

clinical trial
phase ii
double blind
open label
study protocol
phase iii
acute heart failure
heart failure
randomized controlled trial
combination therapy
cell free
free survival